(FG) F&G Annuities Life - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30190A1043

FG: Annuities, Insurance, Life Insurance, Fixed Annuities

F&G Annuities & Life Inc. (NYSE:FG) is a prominent provider of fixed annuities and life insurance products in the United States. Established in 1959 and headquartered in Des Moines, Iowa, the company operates as a subsidiary of Fidelity National Financial, Inc., leveraging the stability and resources of its parent organization. F&Gs product portfolio is designed to meet diverse customer needs, offering fixed indexed annuities, multi-year guarantee annuities, and pension risk transfer solutions. Additionally, they provide indexed universal life insurance and institutional funding agreements, catering to both retail and institutional clients.

The companys financial standing is notable, with a market capitalization of approximately $5.85 billion. While the current P/E ratio is 0.00, the forward P/E is 4.86, indicating expected earnings growth. The price-to-book ratio of 1.35 suggests that investors value the companys assets appropriately. With a price-to-sales ratio of 1.00, F&G demonstrates a balanced approach to revenue generation and profitability.

F&Gs strategic position in the market is strengthened by its focus on predictable income products, which are particularly appealing in volatile economic conditions. The inclusion of indexed products allows for controlled market exposure, enhancing appeal to risk-conscious investors. Their expertise in pension risk transfers addresses a critical need for corporations seeking to manage liabilities, positioning F&G as a key player in this growing sector.

As a subsidiary of Fidelity National Financial, F&G benefits from a robust financial framework and extensive industry knowledge, enhancing its competitive edge. This affiliation not only provides operational stability but also access to a broader network and resources, enabling F&G to maintain its position as a reliable and innovative insurer in the U.S. market.

Additional Sources for FG Stock

FG Stock Overview

Market Cap in USD 5,551m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 2022-12-01

FG Stock Ratings

Growth 5y 61.2%
Fundamental -13.9%
Dividend 52.0%
Rel. Strength Industry -28.5
Analysts 3/5
Fair Price Momentum 39.06 USD
Fair Price DCF 346.12 USD

FG Dividends

Dividend Yield 12m 2.09%
Yield on Cost 5y 5.35%
Annual Growth 5y 2.44%
Payout Consistency 100.0%

FG Growth Ratios

Growth Correlation 3m -17.7%
Growth Correlation 12m 75.9%
Growth Correlation 5y 85.3%
CAGR 5y 51.30%
CAGR/Max DD 5y 1.24
Sharpe Ratio 12m 0.18
Alpha -34.21
Beta 2.14
Volatility 43.92%
Current Volume 187.3k
Average Volume 20d 78.3k
What is the price of FG stocks?
As of February 23, 2025, the stock is trading at USD 40.18 with a total of 187,343 shares traded.
Over the past week, the price has changed by -14.58%, over one month by -8.41%, over three months by -14.27% and over the past year by -7.04%.
Is F&G Annuities Life a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, F&G Annuities Life is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.90 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FG as of February 2025 is 39.06. This means that FG is currently overvalued and has a potential downside of -2.79%.
Is FG a buy, sell or hold?
F&G Annuities Life has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold FG.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for FG stock price target?
According to ValueRays Forecast Model, FG F&G Annuities Life will be worth about 46.9 in February 2026. The stock is currently trading at 40.18. This means that the stock has a potential upside of +16.65%.
Issuer Forecast Upside
Wallstreet Target Price 47 17%
Analysts Target Price 47 17%
ValueRay Target Price 46.9 16.7%